ADAPTIR
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2024)
What this means for you
This application is over — abandoned 08 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88942264
- Mark type
- Stylized text
- Filed
- 01 Jun 2020
- Published for opposition
- 13 Oct 2020
- Abandoned
- 08 Jan 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 001 — Chemicals: Therapeutic protein molecules used in the manufacture of pharmaceuticals and biologically-derived medical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances, namely, polypeptides, antibodies, and antibody derivatives, for use in the treatment of autoimmune disorders and conditions, and cancer
Owner
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
- APTEVO RESEARCH AND DEVELOPMENT LLC, Seattle, WA, US
Prosecution history
- 08 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2023 — SOU EXTENSION 5 GRANTED
- 06 Jun 2023 — SOU EXTENSION 5 FILED
- 13 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2022 — SOU EXTENSION 4 GRANTED
- 08 Dec 2022 — SOU EXTENSION 4 FILED
- 08 Dec 2022 — SOU TEAS EXTENSION RECEIVED
- 09 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jun 2022 — SOU EXTENSION 3 GRANTED
- 07 Jun 2022 — SOU EXTENSION 3 FILED
- 07 Jun 2022 — SOU TEAS EXTENSION RECEIVED